Loading organizations...
Loading organizations...
Probiotic and pharmabiotic therapies for neutrophilic inflammation.
ResBiotic has raised $11.0M across 2 funding rounds.
ResBiotic has raised $11.0M in total across 2 funding rounds.
ResBiotic has raised $11.0M in total across 2 funding rounds.
ResBiotic's investors include Biostack Ventures, Sororibus Capital, Braxton Goodrich.
ResBiotic has raised $11.0M across 2 funding rounds. Most recently, it raised $8.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 12, 2025 | $8.0M Series A | Biostack Ventures, Sororibus Capital | |
| May 1, 2021 | $3.0M Seed | Braxton Goodrich |